Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Clinical - Phase III
Taxus Cardium (CRXM) Announces Scientific Presentation And Clinical Update On Phase 3 Angiogenic Gene Therapy At The 2015 Phacilitate 11th Annual Cell & Gene Therapy Forum 1/27/2015 10:07:16 AM
Ipsen (IPN.PA) Announces Topline Results Of Two Double-Blind Phase 3 Studies Of Dysport® In Lower Limb Spasticity In Children And In Adults 1/26/2015 10:11:48 AM
CEL-SCI (CVM) Receives Regulatory Clearance To Expand Its Phase 3 Head And Neck Cancer Trial Into Romania 1/26/2015 8:30:32 AM
Shire (SHPGY)'s Investigational SHP609, idursulfase-IT, Receives FDA Fast Track Designation For The Treatment Of Neurocognitive Decline Associated With Hunter Syndrome 1/26/2015 7:29:07 AM
Regeneron (REGN) Release: EYLEA® (aflibercept) Injection Recommended For Approval For The Treatment Of Visual Impairment Due To Macular Edema Secondary To Central Or Branch Retinal Vein Occlusion In The European Union 1/23/2015 10:14:20 AM
Shire plc Release: Positive Response From European Decentralised Procedure For Elvanse Adult® (lisdexamfetamine dimesylate) In Adults With ADHD 1/22/2015 8:07:33 AM
ALPHAEON Begins Phase 3 Study For Its Neurotoxin, EVOSYAL 1/22/2015 8:11:56 AM
FDA Removes Partial Clinical Hold on CytRx Corporation (CYTR)'s Brain Cancer Trials 1/20/2015 6:41:01 AM
The New Billion Dollar Tekmira (TKMR) Includes Promising Hep B Drug 1/19/2015 7:47:24 AM
Clinical Study Results Presented At The 2015 Gastrointestinal Cancer Symposium Support Utility Of Trovagene's Precision Cancer Monitoring Platform In Colorectal And Pancreatic Cancer Patients 1/20/2015 8:07:22 AM
TauRx Therapeutics Release: First Evidence Of Potential Efficacy Of Tau Aggregation Inhibitor Therapy In Alzheimer's Disease 1/20/2015 7:06:25 AM
Choroideremia Research Foundation Release: Groundbreaking Gene Therapy Trial Begins In Philadelphia 1/20/2015 7:05:04 AM
Actavis (ACT), Gedeon Richter Ltd. (RIG2.F) Say Key Drug Cariprazine Effective on Schizophrenia Relapse 1/20/2015 6:00:44 AM
Merrimack Pharmaceuticals Inc. (MACK) Presents Additional Analyses Of Phase 3 MM-398 NAPOLI-1 Study At The American Society of Clinical Oncology 2015 Gastrointestinal Cancers Symposium 1/20/2015 6:53:46 AM
Celator Pharmaceuticals, Inc. Receives FDA Fast Track Designation For CPX-351 For The Treatment Of Elderly Patients With Secondary Acute Myeloid Leukemia 1/20/2015 6:47:19 AM